rs362273

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001388492.1(HTT):​c.7797A>G​(p.Leu2599Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.302 in 1,613,154 control chromosomes in the GnomAD database, including 76,328 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 6303 hom., cov: 33)
Exomes 𝑓: 0.31 ( 70025 hom. )

Consequence

HTT
NM_001388492.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.93

Publications

33 publications found
Variant links:
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
  • Huntington disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • Lopes-Maciel-Rodan syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • juvenile Huntington disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 4-3225692-A-G is Benign according to our data. Variant chr4-3225692-A-G is described in ClinVar as Benign. ClinVar VariationId is 1627136.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.93 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.365 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTTNM_001388492.1 linkc.7797A>G p.Leu2599Leu synonymous_variant Exon 57 of 67 ENST00000355072.11 NP_001375421.1
HTTNM_002111.8 linkc.7797A>G p.Leu2599Leu synonymous_variant Exon 57 of 67 NP_002102.4 P42858

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTTENST00000355072.11 linkc.7797A>G p.Leu2599Leu synonymous_variant Exon 57 of 67 1 NM_001388492.1 ENSP00000347184.5 P42858

Frequencies

GnomAD3 genomes
AF:
0.272
AC:
41363
AN:
151906
Hom.:
6297
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.232
Gnomad AMR
AF:
0.265
Gnomad ASJ
AF:
0.307
Gnomad EAS
AF:
0.379
Gnomad SAS
AF:
0.196
Gnomad FIN
AF:
0.464
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.310
Gnomad OTH
AF:
0.235
GnomAD2 exomes
AF:
0.298
AC:
74155
AN:
248722
AF XY:
0.292
show subpopulations
Gnomad AFR exome
AF:
0.152
Gnomad AMR exome
AF:
0.299
Gnomad ASJ exome
AF:
0.304
Gnomad EAS exome
AF:
0.375
Gnomad FIN exome
AF:
0.457
Gnomad NFE exome
AF:
0.303
Gnomad OTH exome
AF:
0.293
GnomAD4 exome
AF:
0.305
AC:
445815
AN:
1461130
Hom.:
70025
Cov.:
35
AF XY:
0.301
AC XY:
219034
AN XY:
726894
show subpopulations
African (AFR)
AF:
0.149
AC:
5002
AN:
33472
American (AMR)
AF:
0.291
AC:
13004
AN:
44660
Ashkenazi Jewish (ASJ)
AF:
0.302
AC:
7898
AN:
26116
East Asian (EAS)
AF:
0.368
AC:
14591
AN:
39676
South Asian (SAS)
AF:
0.193
AC:
16618
AN:
86232
European-Finnish (FIN)
AF:
0.449
AC:
23948
AN:
53374
Middle Eastern (MID)
AF:
0.137
AC:
792
AN:
5764
European-Non Finnish (NFE)
AF:
0.312
AC:
346299
AN:
1111482
Other (OTH)
AF:
0.293
AC:
17663
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
14707
29415
44122
58830
73537
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11386
22772
34158
45544
56930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.272
AC:
41393
AN:
152024
Hom.:
6303
Cov.:
33
AF XY:
0.274
AC XY:
20385
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.161
AC:
6686
AN:
41476
American (AMR)
AF:
0.265
AC:
4059
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.307
AC:
1065
AN:
3464
East Asian (EAS)
AF:
0.379
AC:
1945
AN:
5136
South Asian (SAS)
AF:
0.196
AC:
942
AN:
4814
European-Finnish (FIN)
AF:
0.464
AC:
4896
AN:
10560
Middle Eastern (MID)
AF:
0.153
AC:
45
AN:
294
European-Non Finnish (NFE)
AF:
0.309
AC:
21035
AN:
67968
Other (OTH)
AF:
0.241
AC:
510
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1488
2975
4463
5950
7438
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.284
Hom.:
10003
Bravo
AF:
0.253
Asia WGS
AF:
0.314
AC:
1092
AN:
3478
EpiCase
AF:
0.295
EpiControl
AF:
0.289

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
6.3
DANN
Benign
0.75
PhyloP100
1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs362273; hg19: chr4-3227419; COSMIC: COSV61864971; COSMIC: COSV61864971; API